Lipocine Inc. (LPCN) vs PAVmed Inc. (PAVM)
A side-by-side comparison of Lipocine Inc. and PAVmed Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LPCN
Lipocine Inc.
$2.07HealthcareDelayed quote: Oct 6, 2026, 2:39 PM EDT
PAVM
PAVmed Inc.
$2.77HealthcareDelayed quote: Oct 6, 2026, 2:39 PM EDT
Total return — LPCN vs PAVM
growth of $100 · dividends reinvested · last 10yLPCN -97.2% (-30.0%/yr)PAVM -100.0% (-54.0%/yr)LPCN compounded faster over this window
Log scale — wide-divergence pair
LPCN PAVM
LPCN vs PAVM: by the numbers
- •PAVM is the larger company ($18M vs $17M market cap).
- •Both run net losses; LPCN's is the smaller (-755.13% vs -10794.64% net margin).
Metrics side by side
Valuation
| Metric | LPCN | PAVM |
|---|---|---|
| P/S ratio | 10.87 | 157.87 |
| P/B ratio | 0.78 | 0.57 |
Profitability
| Metric | LPCN | PAVM |
|---|---|---|
| Gross margin | -334.26% | -354.93% |
| Operating margin | -524.69% | -30712.68% |
| Net margin | -755.13% | -10794.64% |
| ROE | -54.45% | -34.50% |
| ROIC | -57.74% | -73.92% |
Growth (annualized)
| Metric | LPCN | PAVM |
|---|---|---|
| Total return CAGR (5Y) | -34.76% | -76.55% |
Frequently asked
- How have LPCN and PAVM total returns compared?
- Over the past 10 years, LPCN delivered -29.99% and PAVM delivered -54.03% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.